FirstLight Bio, Inc. — Form D
FirstLight Bio, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2022-04-22. The offering totals $25.4M, of which $25.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-04-22
- Form: D
- Accession: 0001924340-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $25.4M
- Amount sold: $25.4M
- Investors: 10
- Date of first sale: 2022-04-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-442932
Issuer
- Name: FirstLight Bio, Inc.
- CIK: 0001924340
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 920 BROADWAY, 16TH FLOOR, NEW YORK, NY, 10010
- Phone: 650-678-6966
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Ali Behbahani | Director | Littleton, CO |
| Hunter Fraser | Director | New York, NY |
| Carlo Rizzuto, Ph.D. | Director | New York, NY |
| Busser Busser, Ph.D. | Executive Officer | New York, NY |
| Carlo Rizzuto, Ph.D. | Executive Officer | New York, NY |
More